peginterferon alfa-2a
Sign in to saveAlso known as Ro-258310000, Roferon-A, pegylated ifn-alpha-2a, Pegasys
pharmaceutical drug
In the Vinony graph
Vinony's link graph records 401 inbound references to peginterferon alfa-2a, and connects out to interferon type I, tumor necrosis factor and interferon gamma.
Vinony files it under Antiviral drugs, Chemical articles with multiple CAS registry numbers and Chemicals that do not have a ChemSpider ID assigned.
Vinony links it to 19 Wikipedia language editions.
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Protein
- First approval
- 2002
- Admin. routes
- parenteral
- Indications
- chronic hepatitis B virus infection, chronic hepatitis C virus infection, hepatitis C virus infection, HIV infection
via ChEMBL · EBI
Research
4,356 papers- Peginterferon alfa-2a: a review of approved and investigational uses.Clinical therapeutics · 2004
- Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals.Hepatobiliary & pancreatic diseases international : HBPD INT · 2017
- Peginterferon alfa-2a (40KD) (Pegasys) for the treatment of patients with chronic hepatitis C.International journal of clinical practice · 2003
- Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.Hepatology (Baltimore, Md.) · 2004
- Use of peginterferon alfa-2a (40 KD) (Pegasys) for the treatment of hepatitis C.Advanced drug delivery reviews · 2002
via PubMed
Wikidata facts
- Has use
- medication
Show 5 more facts
- Commons category
- Interferon-alpha 2a
- defined daily dose
- 26
- subject has role
- essential medicine
- has characteristic
- biopharmaceutical
- legal status (medicine)
- boxed warning
via Wikidata · CC0
Categories
Antiviral drugsChemical articles with multiple CAS registry numbersChemicals that do not have a ChemSpider ID assignedChemicals using indexlabelsCYP1A2 inhibitorsDrugboxes which contain changes to verified fieldsDrugs developed by GenentechDrugs developed by Hoffmann-La RocheDrugs with non-standard legal statusImmunostimulantsInfobox drug articles without a structure imageMultiple chemicals in Infobox drugWithdrawn drugsWorld Health Organization essential medicines